HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of liver fibrosis by solubilized coenzyme Q10: Role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression.

Abstract
Coenzyme Q10 (CoQ10), an endogenous antioxidant, is important in oxidative phosphorylation in mitochondria. It has anti-diabetic and anti-cardiovascular disease effects, but its ability to protect against liver fibrosis has not been studied. Here, we assessed the ability of solubilized CoQ10 to improve dimethylnitrosamine (DMN)-induced liver fibrogenesis in mice. DMN treatments for 3 weeks produced a marked liver fibrosis as assessed by histopathological examination and tissue 4-hydroxyproline content. Solubilized CoQ10 (10 and 30 mg/kg) significantly inhibited both the increases in fibrosis score and 4-hydroxyproline content induced by DMN. Reverse transcription-polymerase chain reaction and Western blot analyses revealed that solubilized CoQ10 inhibited increases in the transforming growth factor-beta1 (TGF-beta1) mRNA and alpha-smooth muscle actin (alpha-SMA) protein by DMN. Interestingly, hepatic glutamate-cysteine ligase (GCL) and glutathione S-transferase A2 (GSTA2) were up-regulated in mice treated with CoQ10. Solubilized CoQ10 also up-regulated antioxidant enzymes such as catalytic subunits of GCL and GSTA2 via activating NF-E2 related factor2 (Nrf2)/antioxidant response element (ARE) in H4IIE hepatoma cells. Moreover, CoQ10's inhibition of alpha-SMA and TGF-beta1 expressions disappeared in Nrf2-null MEF cells. In contrast, Nrf2 overexpression significantly decreased the basal expression levels of alpha-SMA and TGF-beta1 in Nrf2-null MEF cells. These results demonstrated that solubilized CoQ10 inhibited DMN-induced liver fibrosis through suppression of TGF-beta1 expression via Nrf2/ARE activation.
AuthorsHoo-Kyun Choi, Yuba Raj Pokharel, Sung Chul Lim, Hyo-Kyung Han, Chang Seon Ryu, Sang Kyum Kim, Mi Kyong Kwak, Keon Wook Kang
JournalToxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 240 Issue 3 Pg. 377-84 (Nov 01 2009) ISSN: 1096-0333 [Electronic] United States
PMID19647758 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Actins
  • DNA Primers
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Transforming Growth Factor beta1
  • Ubiquinone
  • coenzyme Q10
Topics
  • Actins (biosynthesis)
  • Animals
  • Base Sequence
  • Cell Line, Tumor
  • DNA Primers
  • Liver Cirrhosis (metabolism, prevention & control)
  • Male
  • Mice
  • Mice, Inbred ICR
  • NF-E2-Related Factor 2 (physiology)
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • Solubility
  • Transforming Growth Factor beta1 (biosynthesis, metabolism)
  • Ubiquinone (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: